References
  1. Zhang et al. Impact of allergen immunotherapy in allergic asthma. Immunotherapy, 2018 PMID 29569506
  2. Jansen K, Cevhertas L, Ma S, Satitsuksanoa P, Akdis M, van de Veen W. Regulatory B cells, A to Z. Allergy. 2021 Sep;76(9):2699-2715. doi: 10.1111/all.14763. PMID: 33544905.
  3. Huai et al. TGF-β-secreting regulatory B cells: unsung players in immune regulation. Clinical and Translational Immunology, 2021 PMID 33815797
  4. Lee, et al. Allergen-specific transforming growth factor-β-producing CD19+CD5+ regulatory B-cell (Br3) responses in human late eczematous allergic reactions to cow’s milk. J Interferon Cytokine Research, 2011 PMID 21291325
  5. Liu BS, Cao Y, Huizinga TW, Hafler DA, Toes RE. TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur J Immunol. 2014 Jul;44(7):2121-9. doi: 10.1002/eji.201344341. Epub 2014 Apr 16. PMID: 24737107.
  6. Gerth van Wijk R, Dahl R. Pros and cons: Should allergen immunotherapy be considered in all patients with allergic asthma? Allergy. 2022 Mar;77(3):1070-1072. doi: 10.1111/all.15123. Epub 2021 Oct 18. PMID: 34608654.
  7. Yilmaz V, et al. Regulatory B cells in myasthenia gravis are differentially affected by therapies. Ann Clin Transl Neurol. 2018 Sep 22;5(11):1408-1414. PMID: 30480034